Instituto de Investigaciones Clínicas San Nicolás

Somos un centro médico con una trayectoria en investigación farmacológica de más de 10 años. Contamos con un equipo de trabajo en capacitación permanente en el área de ensayos clínicos. Además, contamos con amplia experiencia en protocolos de diferentes especialidades (cardiología, diabetes, reumatología, nefrología, gastroenterología, etc.) y con instalaciones adecuadas para llevar a cabo esta tarea. Estamos disponibles de lunes a viernes de 08:00 a 15:00 hs.
logoInstituto de Investigaciones Clínicas San Nicolás
Pellegrini 346, San Nicolás
Select an option

Specializations

Hígado graso
Cardiovascular

Our team

Medical staff
Ruben Omar Garcia Duran
Marisa Vico
Celso Fernando García
María Florencia Fernandez
Natalia Cantero
Mariana Salcedo

Open studies

Cardiovascular disease
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation - ZEUS - Novo Nordisk A/SSee more
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels - REDEFINE 3 - Novo Nordisk A/SSee more
Diabetes
A Research Study to See How Much CagriSema (1.0 mg Once Weekly) Lowers Blood Sugar and Body Weight Compared to Tirzepatide (5 mg Once Weekly) in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both - REIMAGINE 5 - Novo Nordisk A/SSee more
Heart failure
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Inflammation
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Obesity
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels - REDEFINE 3 - Novo Nordisk A/SSee more
Renal disease
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation - ZEUS - Novo Nordisk A/SSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy